<table>
<colgroup>
<col width="1%" />
<col width="1%" />
<col width="8%" />
<col width="1%" />
<col width="84%" />
<col width="1%" />
<col width="1%" />
<col width="0%" />
</colgroup>
<thead>
<tr>
<th align="left"></th>
<th align="left">gs_id</th>
<th align="left">gs_description</th>
<th align="right">gs_pvalue</th>
<th align="left">gs_genes</th>
<th align="right">gs_de_count</th>
<th align="right">gs_bg_count</th>
<th align="right">Expected</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">GO:0002250</td>
<td align="left">GO:0002250</td>
<td align="left">adaptive immune response</td>
<td align="right">0</td>
<td
align="left">ASCL2,B2M,BCL6,BTN3A1,BTN3A2,BTN3A3,C1QB,C1R,C1RL,C1S,C2,C3,C4A,C4B,CD1A,CD1C,CD274,CD28,CD40,CD69,CD7,CD74,CD80,CEACAM1,CLEC10A,CLEC6A,CR1L,CSF2RB,CTLA4,CTSL,CTSS,CX3CR1,ERAP2,EXO1,FGL1,GPR183,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HLA-H,ICAM1,IL12A,IL12RB1,IL18BP,IL27,IL4I1,IRF1,IRF4,IRF7,ITK,JAK2,JAK3,KLRK1,LAG3,LAMP3,LILRA1,LILRB3,LTA,LYN,MCOLN2,NOD2,P2RX7,PARP3,PCYT1A,PDCD1,PDCD1LG2,RELB,RIPK2,RNF19B,RSAD2,SECTM1,SERPING1,SIT1,SLAMF1,SLAMF6,SLAMF7,SLC11A1,TAP1,TAP2,TBX21,TLR8,TNFRSF11A,TNFRSF14,TNFRSF21,TNFSF13B,TNFSF18,UNG,ZC3H12A</td>
<td align="right">103</td>
<td align="right">384</td>
<td align="right">23.25</td>
</tr>
<tr>
<td align="left">GO:0002503</td>
<td align="left">GO:0002503</td>
<td align="left">peptide antigen assembly with MHC class II protein
complex</td>
<td align="right">0</td>
<td
align="left">B2M,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5</td>
<td align="right">13</td>
<td align="right">13</td>
<td align="right">0.79</td>
</tr>
<tr>
<td align="left">GO:0019886</td>
<td align="left">GO:0019886</td>
<td align="left">antigen processing and presentation of exogenous
peptide antigen via MHC class II</td>
<td align="right">0</td>
<td
align="left">B2M,CD74,CTSL,CTSS,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5</td>
<td align="right">16</td>
<td align="right">27</td>
<td align="right">1.63</td>
</tr>
<tr>
<td align="left">GO:0001916</td>
<td align="left">GO:0001916</td>
<td align="left">positive regulation of T cell mediated
cytotoxicity</td>
<td align="right">0</td>
<td
align="left">B2M,CD1A,CD1C,HLA-A,HLA-B,HLA-C,HLA-DRA,HLA-DRB1,HLA-E,HLA-F,HLA-G,HLA-H,IL12A,IL12RB1,P2RX7,TAP2</td>
<td align="right">16</td>
<td align="right">31</td>
<td align="right">1.88</td>
</tr>
<tr>
<td align="left">GO:0045087</td>
<td align="left">GO:0045087</td>
<td align="left">innate immune response</td>
<td align="right">0</td>
<td
align="left">ACOD1,ADAM8,AIM2,APOBEC3A,APOBEC3D,APOBEC3G,APOL1,APPL2,AURKB,B2M,C1QB,C1R,C1RL,C1S,C2,C3,C4A,C4B,CALCOCO2,CALHM6,CASP4,CCL5,CD274,CD300H,CD300LF,CD40,CD74,CEACAM1,CFB,CFH,CIITA,CLEC10A,CLEC6A,COLEC12,CSF1,CTSS,CX3CR1,CXCL10,CYLD,DDX60,DTX3L,EDN1,FCN1,GBP1,GBP2,GBP3,GBP4,GBP5,GBP6,GBP7,GCH1,GRAMD4,GSDMD,H2BC21,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-E,HLA-F,HLA-G,IFI27,IFI35,IFIH1,IFIT2,IFIT3,IFIT5,IFITM1,IFITM2,IFITM3,IL12A,IL12RB1,IL27,IRF1,IRF4,IRF7,ISG20,JAK2,JAK3,KLRK1,LAG3,LILRA2,LYN,MCOLN2,MEFV,MSRB1,NCF1,NLRC5,NMI,NOD2,NUB1,OAS2,OAS3,OPTN,P2RX7,PARP14,PARP9,PIM1,PLSCR1,PML,PYHIN1,RAB20,RELB,RIPK2,RNF19B,RSAD2,SCIMP,SERINC5,SERPING1,SLAMF1,SLAMF6,SLAMF7,SLAMF8,SLC11A1,STAT1,STAT2,TANK,TICAM2,TIFA,TIFAB,TLR10,TLR5,TLR7,TLR8,TNFRSF14,TRAFD1,TRIM17,TRIM22,TRIM31,TRIM69,TYRO3,UBD,UBE2L6,ZBP1,ZNFX1</td>
<td align="right">135</td>
<td align="right">784</td>
<td align="right">47.47</td>
</tr>
<tr>
<td align="left">GO:0034341</td>
<td align="left">GO:0034341</td>
<td align="left">response to type II interferon</td>
<td align="right">0</td>
<td
align="left">ACOD1,CALCOCO2,CCL5,CD40,CD74,CIITA,EDN1,GBP1,GBP2,GBP3,GBP4,GBP5,GBP6,GBP7,GCH1,HLA-DPA1,IFITM1,IFITM2,IFITM3,IL12RB1,IRF1,JAK2,MEFV,NLRC5,NUB1,PARP14,PARP9,PIM1,RAB20,SLC11A1,STAT1,UBD</td>
<td align="right">32</td>
<td align="right">110</td>
<td align="right">6.66</td>
</tr>
</tbody>
</table>
